Physician profile
Jonathan Michael White
NPI 1538452438
$335.01
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $16.67 · 2022: $62.31.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $160.63 | 2019 | |
| Astellas Pharma US INC | $34.23 | 2022 | |
| Novo Nordisk INC | $21.23 | 2019 | |
| Genentech USA, INC. | $16.67 | 2020 | |
| Amgen INC. | $15.41 | 2019 | |
| Abbvie INC. | $15.35 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.08 | 2019 | |
| Sanofi Pasteur INC. | $14.97 | 2019 | |
| Allergan, INC. | $14.51 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.20 | 2019 | |
| Bioventus LLC | $12.73 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.